Gastroenterology
Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation
Seo Yeon Yoo, Eunju Kim, Gi-Byoung Nam, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee, Jonggi Choi
Korean J Intern Med. 2022;37(3):555-566. Published online January 26, 2022
Background/Aims: The safety of direct oral anticoagulants (DOACs) compared with warfarin in patients with both nonvalvular atrial fibrillation (AF) and clinically confirmed liver cirrhosis (LC) has not been well studied. We compared the risk of a major bleeding event between DOAC and warfarin treatm..
|